At the end of the latest market close, Johnson & Johnson (JNJ) was valued at $162.83. In that particular session, Stock kicked-off at the price of $163.64 while reaching the peak value of $164.75 and lowest value recorded on the day was $162.66. The stock current value is $163.43.
Recently in News on March 29, 2021, Johnson & Johnson Announces Advance Purchase Agreement with the African Vaccine Acquisition Task Team for the Company’s COVID-19 Vaccine Candidate. Up to 400 million doses of the Company’s single-shot vaccine candidate will be made available to African Union member states. You can read further details here
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .
Johnson & Johnson had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $173.65 on 01/26/21, with the lowest value was $151.47 for the same time period, recorded on 03/04/21.
Johnson & Johnson (JNJ) full year performance was 22.74%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Johnson & Johnson shares are logging -5.89% during the 52-week period from high price, and 28.46% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $127.22 and $173.65.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 7383518 for the day, which was evidently lower, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Johnson & Johnson (JNJ) recorded performance in the market was 3.84%, having the revenues showcasing 3.84% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 434.28B, as it employees total of 134500 workers.
The Analysts eye on Johnson & Johnson (JNJ)
During the last month, 10 analysts gave the Johnson & Johnson a BUY rating, 2 of the polled analysts branded the stock as an OVERWEIGHT, 5 analysts were recommending to HOLD this stock, 1 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 157.40, with a change in the price was noted +21.18. In a similar fashion, Johnson & Johnson posted a movement of +14.89% for the period of last 100 days, recording 7,967,717 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for JNJ is recording 0.56 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.52.
Technical rundown of Johnson & Johnson (JNJ)
Raw Stochastic average of Johnson & Johnson in the period of last 50 days is set at 53.92%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 67.42%. In the last 20 days, the company’s Stochastic %K was 69.00% and its Stochastic %D was recorded 74.32%.
Considering, the past performance of Johnson & Johnson, multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 3.84%. Additionally, trading for the stock in the period of the last six months notably improved by 10.94%, alongside a boost of 22.74% for the period of the last 12 months. The shares increased approximately by -0.91% in the 7-day charts and went down by 6.77% in the period of the last 30 days. Common stock shares were driven by 3.84% during last recorded quarter.